investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
NAPTA: Optimizing clinical trial design & delivery of particle therapy for cancer
Mack Roach
17 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
David S Robin
Lawrence Berkeley National Laboratory (DOE)
Berkeley, United States
Eleanor A Blakely
Lawrence Berkeley National Laboratory (DOE)
Berkeley, United States
Yair Censor
University of Haifa
Haifa, Israel
Katvia Mishra
University of California, San Francisco
San Francisco, United States
Igor Barani
University of California, San Francisco
San Francisco, United States
Bruce Faddegon
University of California, San Francisco
San Francisco, United States
Oliver Jäkel
University Hospital Heidelberg
Heidelberg, Germany
Quynh-Thu X Le
Stanford University
Stanford, United States
Lei Xing
Stanford University
Stanford, United States
Amato J Giaccia
Stanford University
Stanford, United States
Hak Choy
Southwestern Medical Center
Dallas, United States
John Schmerge
SLAC National Accelerator Laboratory (DOE)
Menlo Park, United States
Tadashi Kamada
National Institute of Radiological Sciences
Chiba, Japan
Pascal Pommier
Centre Léon Bérard
Lyon, France
Reinhard W Schulte
Loma Linda University
Loma Linda, United States
Mack Roach
Peter MacCallum Cancer Centre
Melbourne, Australia
University of California, San Francisco
San Francisco, United States
Bernt Nordin
Lioness Light Ions
Stockholm, Sweden
Ramona Mayer
EBG MedAustron GmbH
Wiener Neustadt, Austria
Related projects
Hiram Gay
Radiation Oncology Exchange Program
All cancers but non-melanoma skin cancer
Radiation Oncology
Natia Esiashvili
Workshop for pediatric radiation oncologists from low and middle-income countries
All cancers but non-melanoma skin cancer
Radiation Oncology
Hak Choy
National Particle Therapy Research Center (NPTRC)
All cancers but non-melanoma skin cancer
Radiation Oncology
Matthew Bieniosek
Electro-optical Approach to Achieve Time-of-Flight PET/MRI for Cancer Imaging
All cancers but non-melanoma skin cancer
Radiation Oncology
Sam Beddar
Real-time volumetric scintillation dosimetry for radiation therapy
All cancers but non-melanoma skin cancer
Radiation Oncology
Jeremy M Wolfe
Prevalence effects in visual search: Theoretical and practical implications
All cancers but non-melanoma skin cancer
Radiation Oncology
Heike Elizabeth Daldrup-Link
Personalized Whole Body Staging for Children with Cancer: A Solution to the Conundrum of Long-Term Side Effects from CT and PET/CT Scans
All cancers but non-melanoma skin cancer
Radiation Oncology
Global Noncommunicable Diseases Intiatives
Cancer is not a death sentence
All cancers but non-melanoma skin cancer
Global Noncommunicable Diseases Intiatives
Informative-Health assistance seminary for children with pathologies, consequences of Chernobyl.
All cancers but non-melanoma skin cancer
